Huadong Medicine Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000011S1
CNY
36.40
-0.52 (-1.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

9.92 M

Shareholding (Jun 2017)

FII

0.05%

Held by 1 FIIs

DII

99.95%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

With ROE of 15.20%, it has a very attractive valuation with a 3.05 Price to Book Value

  • Over the past year, while the stock has generated a return of 17.84%, its profits have risen by 16.4% ; the PEG ratio of the company is 1.2
  • At the current price, the company has a high dividend yield of 2.3
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 69,463 Million (Large Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.35%

stock-summary
Debt Equity

0.06

stock-summary
Return on Equity

15.22%

stock-summary
Price to Book

2.88

Revenue and Profits:
Net Sales:
10,989 Million
(Quarterly Results - Sep 2025)
Net Profit:
939 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.5%
0%
-9.5%
6 Months
-17.27%
0%
-17.27%
1 Year
4.27%
0%
4.27%
2 Years
15.56%
0%
15.56%
3 Years
-22.39%
0%
-22.39%
4 Years
-0.55%
0%
-0.55%
5 Years
45.6%
0%
45.6%

Huadong Medicine Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
4.69%
EBIT Growth (5y)
7.58%
EBIT to Interest (avg)
36.90
Debt to EBITDA (avg)
0.10
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
1.55
Tax Ratio
17.97%
Dividend Payout Ratio
46.39%
Pledged Shares
0
Institutional Holding
0.05%
ROCE (avg)
17.22%
ROE (avg)
14.25%

Valuation key factors

Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
3.05
EV to EBIT
16.40
EV to EBITDA
13.50
EV to Capital Employed
3.05
EV to Sales
1.71
PEG Ratio
1.23
Dividend Yield
2.25%
ROCE (Latest)
18.59%
ROE (Latest)
15.20%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2017stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.05%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 0.46% vs 2.44% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 5.53% vs -2.70% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,989.20",
          "val2": "10,939.10",
          "chgp": "0.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,106.90",
          "val2": "1,322.50",
          "chgp": "-16.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "30.40",
          "val2": "30.20",
          "chgp": "0.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "938.50",
          "val2": "889.30",
          "chgp": "5.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "100.70%",
          "val2": "97.30%",
          "chgp": "0.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 3.02% vs 7.74% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 22.76% vs 12.39% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "41,655.10",
          "val2": "40,435.20",
          "chgp": "3.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,178.90",
          "val2": "4,406.20",
          "chgp": "17.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "123.70",
          "val2": "144.20",
          "chgp": "-14.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.90",
          "val2": "-7.00",
          "chgp": "141.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,494.20",
          "val2": "2,846.40",
          "chgp": "22.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "103.60%",
          "val2": "88.70%",
          "chgp": "1.49%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
10,989.20
10,939.10
0.46%
Operating Profit (PBDIT) excl Other Income
1,106.90
1,322.50
-16.30%
Interest
30.40
30.20
0.66%
Exceptional Items
0.00
0.00
Consolidate Net Profit
938.50
889.30
5.53%
Operating Profit Margin (Excl OI)
100.70%
97.30%
0.34%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 0.46% vs 2.44% in Jun 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 5.53% vs -2.70% in Jun 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
41,655.10
40,435.20
3.02%
Operating Profit (PBDIT) excl Other Income
5,178.90
4,406.20
17.54%
Interest
123.70
144.20
-14.22%
Exceptional Items
2.90
-7.00
141.43%
Consolidate Net Profit
3,494.20
2,846.40
22.76%
Operating Profit Margin (Excl OI)
103.60%
88.70%
1.49%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 3.02% vs 7.74% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 22.76% vs 12.39% in Dec 2023

stock-summaryCompany CV
About Huadong Medicine Co., Ltd. stock-summary
stock-summary
Huadong Medicine Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available